OMEROS CORP Share-based Goods and Nonemployee Services Transaction, Quantity of Securities Issued
OMEROS CORP (OMER) reported Share-based Goods and Nonemployee Services Transaction, Quantity of Securities Issued of 20.00 thousand shares for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-01.
Discontinued › Notes › Compensation Related Costs
us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued · last filed 2019-03-01
- OMEROS CORP share-based goods and nonemployee services transaction, quantity of securities issued for fiscal 2018 was 20.00K shares, a 20.00% decline from fiscal 2017.
- OMEROS CORP share-based goods and nonemployee services transaction, quantity of securities issued for fiscal 2017 was 25.00K shares, a 34.21% decline from fiscal 2016.
- OMEROS CORP share-based goods and nonemployee services transaction, quantity of securities issued for fiscal 2016 was 38.00K shares, a 804.76% increase from fiscal 2015.
- OMEROS CORP share-based goods and nonemployee services transaction, quantity of securities issued for fiscal 2015 was 4.20K shares, a 95.12% decline from fiscal 2014.
| Period end | Share-based Goods and Nonemployee Services Transaction, Quantity of Securities Issued 12 month | Share-based Goods and Nonemployee Services Transaction, Quantity of Securities Issued 12 month as first filed |
|---|---|---|
| 2018-12-31 | 20.00K shares 10-K · filed 2019-03-01 | |
| 2017-12-31 | 25.00K shares 10-K · filed 2019-03-01 | |
| 2016-12-31 | 38.00K shares 10-K · filed 2018-03-01 | |
| 2015-12-31 | 4.20K shares 10-K · filed 2018-03-01 | |
| 2014-12-31 | 86.00K shares 10-K · filed 2017-03-16 | 86.50K shares 10-K · filed 2015-03-16 |
| 2013-12-31 | 40.00K shares 10-K · filed 2016-03-15 | |
| 2012-12-31 | 28.00K shares 10-K · filed 2015-03-16 | |
| 2011-12-31 | 15.00K shares 10-K · filed 2014-03-13 | |
| 2010-12-31 | 9.60K shares 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |